Jennifer Pellet

As editor-at-large at Chief Executive magazine, Jennifer Pellet writes feature stories and CEO roundtable coverage and also edits various sections of the publication.


Sort by: Article Title Contributor Topic Date

The DNA of Disruptive Innovation

For the past 30 years pharma has thrived on big molecule breakthroughs and savvy marketing, but that model has been challenged by an environment of skyrocketing health care spending, rising development costs and intensifying competition from generics. Clearly, pharma needs a way to rethink its business—change its DNA—and re-invent and renew itself by rethinking the entire end-to-end value chain.

Jennifer Pellet CEO Briefing Newsletter , Leadership & Strategy July 22 2013

Lifeway’s Julie Smolyansky: A Healthy Start

At 27, she inherited a CEO role—and the job of taking a milk product mainstream.

Jennifer Pellet CEO Briefing Newsletter , CEO Interviews July 19 2013

Rytec’s Don Grasso: Vertical Man

An investment banker turned CEO shares his strategy on buying and building a mid-size company.

Jennifer Pellet CEO Briefing Newsletter May 27 2013

Medifast’s Michael MacDonald: All in the Family

How a 33-year Xerox veteran made good at his ailing brother’s diet food company.

Jennifer Pellet CEO Briefing Newsletter May 24 2013

Shaping a Culture that Drives Agility and Innovation

CEOs ponder the intangible asset that can make or break a company’s future.

Jennifer Pellet March 25 2013

Swisse Vitamin’s Radek Sali: The Natural

An Australian CEO shares his strategy for translating his marketing juggernaut’s success stateside.

Jennifer Pellet CEO Briefing Newsletter March 15 2013

Case Study: Partnering for Potential, Array BioPharma’s Ron Squarer

You’ve stepped in as CEO at a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs used to treat cancer and inflammatory diseases. In taking the helm, you’re charged with finishing the company’s 10-year transition from developing drugs for larger pharma companies to steering some of those molecules through late-stage development and commercialization on its own.

Jennifer Pellet CEO Briefing Newsletter March 12 2013

A Better Way to Build

Ann Hand, CEO of Project Frog, wants to “democratize” high-functioning buildings—delivering high-end design at value prices through pre-fab construction.

Jennifer Pellet CEO Briefing Newsletter , CEO Interviews February 1 2013

Controlling Health Care Costs

Pockets where breakthrough successes have occurred suggest there are ways to contain the spiraling cost of health care.

Jennifer Pellet CEO Briefing Newsletter , Governance/Compliance , Leadership & Strategy January 25 2013

What has Facebook Done for You Lately?

Hill Holliday’s Mike Sheehan on social media.

Jennifer Pellet CEO Interviews November 1 2012

CEO Leadership Insights

Sign up now to receive your free CEO Briefing. Delivered weekly, this e-newsletter provides CEOs with valuable insights on leadership, strategy, growth and much more.